Novo Nordisk A/S (NYSE: NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Prompt injection attacks can manipulate AI behavior in ways that traditional cybersecurity ...

The World Anti-Doping Agency is investigating whether ski jumpers were injecting their penises with hyaluronic acid in order to fly further In the quest for Olympic gold, professional athletes endure ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

TAIPEI (Taiwan News) — Taiwan’s Food and Drug Administration on Saturday reported 21 suspected cases of adverse reactions linked to weight-loss injections over the past three years. Weight-loss ...

A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...

Feb 4 (Reuters) - Eli Lilly forecast strong growth for 2026 on Wednesday ‌on the back of surging obesity drug demand, shaking off pricing pressures ‌that helped sink rival Novo Nordisk's outlook. The ...

Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...

Eli Lilly released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for the ...